FDA Inspection 1088024 — Kadri Tamme
The FDA completed an inspection of Kadri Tamme on April 23, 2019 in Tartu. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 23, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Tartu (Estonia)
Additional Details
Clinical Investigator (CI)